Tsumura & Co. (OTCMKTS:TSMRF – Get Free Report) will likely be announcing its resultson Wednesday, May 13th. Analysts expect the company to announce earnings of $0.5870 per share and revenue of $316.8150 million for the quarter.
Tsumura & Co. Stock Performance
OTCMKTS TSMRF opened at $23.20 on Wednesday. Tsumura & Co. has a one year low of $23.20 and a one year high of $25.75. The stock’s 50 day simple moving average is $23.20 and its 200 day simple moving average is $23.20.
Tsumura & Co. Company Profile
Tsumura & Co is a Tokyo?based pharmaceutical company specializing in the research, development and manufacture of Kampo medicines, which are traditional Japanese herbal remedies rooted in Chinese materia medica. The company’s core business revolves around the extraction, standardization and quality control of crude herbal ingredients, transforming them into prescription?grade and over?the?counter products that are approved under Japan’s national health insurance system.
Leveraging a combination of modern analytical technology and traditional knowledge, Tsumura produces a broad portfolio of Kampo formulations for a range of therapeutic applications, including gastrointestinal health, circulatory support and immune regulation.
Featured Stories
Receive News & Ratings for Tsumura & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tsumura & Co. and related companies with MarketBeat.com's FREE daily email newsletter.
